학술논문
Stage-II thymoma and emergency coronary artery bypass. To irradiate or not to irradiate to avoid radiation induced vascular injury? Case report and literature review.
Document Type
Academic Journal
Author
Kouerinis IA; First Department of Cardiothoracic Surgery, Hippokration University Hospital, Athens, Greece.; Tolia M; Zagouri F; Nikolaou M; Tsoukalas N; Kyrgias G; Dimopoulos MA; Vlachopoulos C; Karathanassis I; Zoubouli CK; Kokakis I; Kouloulias V; Triantafillou K
Source
Publisher: BAKIS Productions LTD Country of Publication: Cyprus NLM ID: 100883428 Publication Model: Print Cited Medium: Print ISSN: 1107-0625 (Print) Linking ISSN: 11070625 NLM ISO Abbreviation: J BUON
Subject
Language
English
ISSN
1107-0625
Abstract
Purpose: The purpose of this study was to present the controversial role of adjuvant radiotherapy to a 72-year-old male patient with Masaoka stage II thymoma and coronary artery bypass and to review the relevant literature.
Methods: The data were collected by relevant studies on PubMed and EMBASE. Articles up to March 2017 were included.
Results: Although the radiation-induced vascular injury to the internal thoracic artery and its suitability for grafting in a patient who is candidate for coronary artery bypass is documented, the possible catastrophic effect of adjuvant radiotherapy to existing grafts in a patient with prior bypass surgery has not been fully investigated.
Conclusion: The application of radiotherapy in a patient with R0 stage II thymoma is currently considered of 2B level of evidence but its potential occlusive effect to an underlying coronary graft may dramatically affect the survival of the patient and accordingly drop the level of evidence of its use.
Methods: The data were collected by relevant studies on PubMed and EMBASE. Articles up to March 2017 were included.
Results: Although the radiation-induced vascular injury to the internal thoracic artery and its suitability for grafting in a patient who is candidate for coronary artery bypass is documented, the possible catastrophic effect of adjuvant radiotherapy to existing grafts in a patient with prior bypass surgery has not been fully investigated.
Conclusion: The application of radiotherapy in a patient with R0 stage II thymoma is currently considered of 2B level of evidence but its potential occlusive effect to an underlying coronary graft may dramatically affect the survival of the patient and accordingly drop the level of evidence of its use.